Foundation-model platform for designing sequence-based medicines including siRNA, ASO, mRNA, and peptides.
View competitors
RNA design firm using deep learning and high-throughput experiments to create innovative medicines and biotechnologies.
Inceptive, founded with the mission to revolutionize the field of biotechnology, focuses on designing RNA molecules using advanced deep learning techniques combined with high-throughput experiments. The company aims to create powerful biological software that enables the rational design of novel and broadly accessible medicines and biotechnologies, pushing the boundaries of what is currently achievable in the field. Their market focus includes pharmaceutical companies and research institutions looking to develop innovative treatments and biotechnological solutions.
Notable individuals affiliated with Inceptive include experts in computational biology and biotechnology, though specific names are not provided. The company has garnered attention for its cutting-edge approach to RNA design, leveraging artificial intelligence to accelerate the development of new therapies. Inceptive's impact is evident in its potential to transform medicine by making advanced biotechnologies more accessible and effective, positioning itself as a leader in the next generation of medical innovation.
Inceptive's most recent funding round was for $100M (USD) in September 2023.
As of Sep 7, 2023, Inceptive has disclosed funding of $120M (USD).
Avacta Group

Vanqua Bio
Readline

Eikon Therapeutics

Vedanta Biosciences

Jacobio Pharma

Brightseed

Starna Therapeutics

Agenus

Ildong Pharmaceutical

Benitec Biopharma

Enanta Pharmaceuticals

ARS Pharmaceuticals

Nautilus Biotechnology

Valerio Therapeutics

Northwest Biotherapeutics

Creyon Bio
creyon.com

Biocytogen
biocytogen.com

Shape Therapeutics
shapetx.com

Wayfinder Biosciences
wayfinderbio.com